10.07.2015 Views

Systematic review, meta-analysis and economic modelling of ...

Systematic review, meta-analysis and economic modelling of ...

Systematic review, meta-analysis and economic modelling of ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

DOI: 10.3310/hta17010 Health Technology Assessment 2013 Vol. 17 No. 1Prognosis-only studies that analyse only troponin <strong>and</strong>/or creatine kinaseMB isoenzyme as variables (n = 18)1. Christ M, Popp S, et al. Implementation <strong>of</strong> High Sensitivity Cardiac Troponin T Measurement in theEmergency Department. Am J Med 2010;123:1134–42.2. deFilippi CR, Tocchi M, Parmar RJ, Rosanio S, Abreo G, Potter MA, et al. Cardiac troponin T in chestpain unit patients without ischemic electrocardiographic changes: angiographic correlates <strong>and</strong>long-term clinical outcomes. J Am Coll Cardiol 2000;35:1827–34.3. deFilippi CR, Parmar RJ, Potter MA, Tocchi M, deFilippi CR, Parmar RJ, et al. Diagnostic accuracy,angiographic correlates <strong>and</strong> long-term risk stratification with the troponin T ultra sensitive RapidAssay in chest pain patients at low risk for acute myocardial infarction. Eur Heart J 1998;(Suppl.19):42–7.4. Goodacre S, Locker T. Which diagnostic tests are most useful in a chest pain unit protocol? BMCEmerg Med 2005;5:6.5. Herkner H, Waldenh<strong>of</strong>er U, Laggner AN, llner M, Oschatz E, Spitzauer S, et al. Clinical application<strong>of</strong> rapid quantitative determination <strong>of</strong> cardiac troponin-T in an emergency department setting.Resuscitation 2001;49:259–64.6. Kontos MC, Shah R, Fritz LM, Anderson FP, Tatum JL, Ornato JP, et al. Implication <strong>of</strong> different cardiactroponin I levels for clinical outcomes <strong>and</strong> prognosis <strong>of</strong> acute chest pain patients. J Am Coll Cardiol2004;43:958–65.7. Kontos MCA. Ability <strong>of</strong> troponin I to predict cardiac events in patients admitted from theemergency department. J Am Coll Cardiol 2000;36:1818–23.8. Koukkunen H, Penttil K, Kemppainen A, Penttil I, et al. Ruling out myocardial infarction withtroponin T <strong>and</strong> creatine kinase MB mass: diagnostic <strong>and</strong> prognostic aspects. Sc<strong>and</strong> Cardiovasc J2001;35:302–6.9. Limkakeng A, Jr, Gibler WB, Pollack C, Hoekstra JW, Sites F, Sh<strong>of</strong>er FS, et al. Combination <strong>of</strong>Goldman risk <strong>and</strong> initial cardiac troponin I for emergency department chest pain patient riskstratification. Acad Emerg Med 2001;8:696–702.10. Meyer T, Binder L, Graeber T, Luthe H, Kreuzer H, Oellerich M, et al. Superiority <strong>of</strong> combined CK-MB<strong>and</strong> troponin I measurements for the early risk stratification <strong>of</strong> unselected patients presenting withacute chest pain. Cardiology 1998;90:286–94.11. Mills NL. Implementation <strong>of</strong> a sensitive troponin i assay <strong>and</strong> risk <strong>of</strong> recurrent myocardial infarction<strong>and</strong> death in patients with suspected acute coronary syndrome. JAMA 2011;305:1210–16.12. Muscholl MW, Oswald M, Mayer C, von SW, Muscholl MW, Oswald M, et al. Prognostic value <strong>of</strong>2D echocardiography in patients presenting with acute chest pain <strong>and</strong> non-diagnostic ECG forST-elevation myocardial infarction. Int J Cardiol 2002;84:217–25.13. Newby LK, Kaplan AL, Granger BB, Sedor F, Califf RM, Ohman EM. Comparison <strong>of</strong> cardiac troponinT versus creatine kinase-MB for risk stratification in a chest pain evaluation unit. Am J Cardiol2000;85:801–5.14. Noeller TP, Meldon SW, Peacock WF, Emerman CL, McErlean ES, Vanlente F, et al. Troponin T inelders with suspected acute coronary syndromes. Am J Emerg Med 2003;21:293–7.15. Peacock WF IV, Emerman CL, McErlean ES, Deluca SA, Van LF, Rao JS, et al. Prediction <strong>of</strong> short<strong>and</strong>long-term outcomes by troponin T levels in low-risk patients evaluated for acute coronarysyndromes. Ann Emerg Med 2000;35:213–20.© Queen’s Printer <strong>and</strong> Controller <strong>of</strong> HMSO 2013. This work was produced by Goodacre et al. under the terms <strong>of</strong> a commissioning contract issued by the Secretary <strong>of</strong> Statefor Health. This issue may be freely reproduced for the purposes <strong>of</strong> private research <strong>and</strong> study <strong>and</strong> extracts (or indeed, the full report) may be included in pr<strong>of</strong>essional journalsprovided that suitable acknowledgement is made <strong>and</strong> the reproduction is not associated with any form <strong>of</strong> advertising. Applications for commercial reproduction should beaddressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials <strong>and</strong> Studies Coordinating Centre, Alpha House, University <strong>of</strong> Southampton SciencePark, Southampton SO16 7NS, UK.147

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!